Table 2.
Parameters associated with NAFLD (CAP ≥ 248 dB/m).
| Variables | Odds Ratio | 95% Confidence Interval | p-Value * |
|---|---|---|---|
| Age, years | 1.01 | 1.00–1.02 | 0.220 |
| Male | 2.30 | 1.82–2.92 | <0.001 |
| Hypertension | 1.62 | 1.26–2.08 | <0.001 |
| Diabetes mellitus | 1.52 | 1.07–2.15 | 0.020 |
| Hypercholesterolemia | 1.50 | 1.16–1.93 | 0.002 |
| Smoking | 1.79 | 1.33–2.41 | <0.001 |
| Body mass index, kg/m2 | 1.29 | 1.24–1.34 | <0.001 |
| BMI ≥ 25, kg/m2 | 5.66 | 4.36–7.36 | <0.001 |
| Fasting glucose, mg/dL | 1.02 | 1.01–1.03 | <0.001 |
| Total cholesterol, mg/dL | 1.00 | 1.00–1.00 | 0.420 |
| Triglyceride, mg/dL + | 5.03 | 3.85–6.58 | <0.001 |
| HDL cholesterol, mg/dL | 0.96 | 0.95–0.97 | <0.001 |
| HS-CRP (mg/dL) | 1.29 | 0.89–1.87 | 0.176 |
| Vitamin D ≥ 20 (vs. <20)(ng/mL) | 0.75 | 0.60–0.95 | 0.014 |
| Vitamin D Quartile | |||
| 1st (–14.6) | 1 (reference) | 0.019 ** | |
| 2nd (14.7–19.5) | 0.82 | 0.59–1.13 | 0.218 |
| 3rd (19.6–26.7) | 0.73 | 0.53–1.01 | 0.056 |
| 4th (26.8–) | 0.60 | 0.44–0.83 | 0.002 |
BMI, body mass index; CAP, controlled attenuation parameter; HDL, high-density lipoprotein; HS-CRP, high sensitivity C-reactive protein. * compared to no NAFLD, ** p for trends,+ log transformed.